Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

MtBE and cancer in animals: statistical issues with poly-3 survival adjustments for lifetime studies.

Kissling GE, Portier CJ, Huff J.

Regul Toxicol Pharmacol. 2008 Apr;50(3):428-9. Epub 2007 Aug 26. No abstract available.

2.

Letter to the editor: effects of MTBE on Leydig cell tumors in Sprague-Dawley rats: range of possible poly-3 results.

Beck B.

Regul Toxicol Pharmacol. 2008 Apr;50(3):430. doi: 10.1016/j.yrtph.2007.07.007. Epub 2007 Aug 26. No abstract available.

PMID:
18423267
3.

Effects of MTBE on the reported incidence of Leydig cell tumors in Sprague-Dawley rats: range of possible Poly-3 results.

Goodman JE, Gaylor D, Beyer LA, Rhomberg LR, Beck BD.

Regul Toxicol Pharmacol. 2008 Apr;50(3):273-84. doi: 10.1016/j.yrtph.2007.12.005. Epub 2007 Dec 27. Review.

PMID:
18241965
4.

Carcinogenicity studies on MTBE: critical review and interpretation.

Mennear JH.

Risk Anal. 1997 Dec;17(6):673-81.

PMID:
9463924
5.

Subchronic studies in Sprague-Dawley rats to investigate mechanisms of MTBE-induced Leydig cell cancer.

de Peyster A, MacLean KJ, Stephens BA, Ahern LD, Westover CM, Rozenshteyn D.

Toxicol Sci. 2003 Mar;72(1):31-42.

PMID:
12604832
6.

Methyl-tertiary-butyl ether (MTBE)--a gasoline additive--causes testicular and lymphohaematopoietic cancers in rats.

Belpoggi F, Soffritti M, Maltoni C.

Toxicol Ind Health. 1995 Mar-Apr;11(2):119-49.

PMID:
7491630
7.

Results of long-term experimental studies on the carcinogenicity of methyl tert-butyl ether.

Belpoggi F, Soffritti M, Filippini F, Maltoni C.

Ann N Y Acad Sci. 1997 Dec 26;837:77-95.

PMID:
9472331
8.

Methyl tertiary-butyl ether mode of action for cancer endpoints in rodents.

Cruzan G, Borghoff SJ, de Peyster A, Hard GC, McClain M, McGregor DB, Thomas MG.

Regul Toxicol Pharmacol. 2007 Mar;47(2):156-65. Epub 2006 Nov 3. Review.

PMID:
17084497
9.

MTBE: not carcinogenic.

Mennear JH.

Environ Health Perspect. 1995 Nov;103(11):985-6. No abstract available.

10.

To MTBE or not to MTBE.

[No authors listed]

Environ Health Perspect. 1994 Nov;102(11):913. No abstract available.

11.

Two-year drinking water carcinogenicity study of methyl tertiary-butyl ether (MTBE) in Wistar rats.

Dodd D, Willson G, Parkinson H, Bermudez E.

J Appl Toxicol. 2013 Jul;33(7):593-606. doi: 10.1002/jat.1776. Epub 2011 Dec 7.

PMID:
22161475
12.

Lifelong exposure to di-(2-ethylhexyl)-phthalate induces tumors in liver and testes of Sprague-Dawley rats.

Voss C, Zerban H, Bannasch P, Berger MR.

Toxicology. 2005 Jan 31;206(3):359-71.

PMID:
15588926
13.

Carcinogenicity in rats of the SGLT2 inhibitor canagliflozin.

De Jonghe S, Proctor J, Vinken P, Feyen B, Wynant I, Marien D, Geys H, Mamidi RN, Johnson MD.

Chem Biol Interact. 2014 Dec 5;224:1-12. doi: 10.1016/j.cbi.2014.09.018. Epub 2014 Oct 5.

PMID:
25289773
14.

Mechanism for species-specific induction of Leydig cell tumors in rats by lansoprazole.

Fort FL, Miyajima H, Ando T, Suzuki T, Yamamoto M, Hamashima T, Sato S, Kitazaki T, Mahony MC, Hodgen GD.

Fundam Appl Toxicol. 1995 Jul;26(2):191-202.

PMID:
7589908
15.

A two-year study with cimetidine in the rat: assessment for chronic toxicity and carcinogenicity.

Leslie GB, Noakes DN, Pollitt FD, Roe FJ, Walker TF.

Toxicol Appl Pharmacol. 1981 Oct;61(1):119-37. No abstract available.

PMID:
7292498
16.
17.

Mutagenicity of methyl tertiary butyl ether.

Zhou W, Yuan D, Huang G, Zhang H, Ye S.

J Environ Pathol Toxicol Oncol. 2000;19(1-2):35-9.

PMID:
10905506
18.

Tumorigenesis by cadmium.

Lucis OJ, Lucis R, Aterman K.

Oncology. 1972;26(1):53-67. No abstract available.

PMID:
4670915
19.

Lifespan carcinogenicity tests with native carrageenan in rats and hamsters.

Rustia M, Shubik P, Patil K.

Cancer Lett. 1980 Nov;11(1):1-10.

PMID:
7226135
20.

Oncogenicity studies of inhaled methyl tertiary-butyl ether (MTBE) in CD-1 mice and F-344 rats.

Bird MG, Burleigh-Flayer HD, Chun JS, Douglas JF, Kneiss JJ, Andrews LS.

J Appl Toxicol. 1997 May;17 Suppl 1:S45-55.

PMID:
9179727

Supplemental Content

Support Center